Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998433401> ?p ?o ?g. }
- W1998433401 endingPage "942" @default.
- W1998433401 startingPage "931" @default.
- W1998433401 abstract "Summary Several new anticoagulants have entered the clinical arena or are under clinical development. These drugs include indirect (fondaparinux) and direct oral factor Xa inhibitors (rivaroxaban, apixaban, edoxaban, betrixaban), and the direct thrombin inhibitor dabigatran. Especially the oral direct FXa and FIIa inhibitors overcome many of the shortcomings of heparins and vitamin K antagonists (VKAs). They are administered orally at a fixed dose; regular monitoring is not necessary; interaction with other drugs or nutrition occur less than with VKAs and they are at least as effective as VKAs for most indications tested. They are associated with about 50 % less intracranial bleeding than VKAs. Nevertheless, they are still associated with bleeding complications. Bleeding can occur spontaneously or as a result of trauma or urgent surgery. In such situations rapid reversal of the anticoagulant effect is highly desirable. For unfractionated heparin protamine, and for VKAs prothrombin complex concentrates are available as specific antidotes. Under clinical development are: for the direct and indirect FXa inhibitors a modified recombinant FXa (andexanet alpha), which lacks enzymatic activity; and for dabigatran a Fab fragment of a monoclonal antibody (idarucizumab). In addition a small molecule (aripazine) has entered phase I clinical trials, which seems to inhibit nearly all anticoagulants but VKAs and argatroban. This review summarises the current options and strategies in development to antagonise anticoagulants with a focus on the status of the development of antidotes for the oral direct FXa and FIIa inhibitors." @default.
- W1998433401 created "2016-06-24" @default.
- W1998433401 creator A5004678737 @default.
- W1998433401 creator A5059559189 @default.
- W1998433401 creator A5075868354 @default.
- W1998433401 date "2015-09-01" @default.
- W1998433401 modified "2023-09-27" @default.
- W1998433401 title "Reversal of anticoagulants: an overview of current developments" @default.
- W1998433401 cites W1515866991 @default.
- W1998433401 cites W1556592242 @default.
- W1998433401 cites W1592798290 @default.
- W1998433401 cites W1940756716 @default.
- W1998433401 cites W1941419043 @default.
- W1998433401 cites W1965344541 @default.
- W1998433401 cites W1971941179 @default.
- W1998433401 cites W1977900178 @default.
- W1998433401 cites W1980009210 @default.
- W1998433401 cites W1984833612 @default.
- W1998433401 cites W2010481138 @default.
- W1998433401 cites W2015751459 @default.
- W1998433401 cites W2016875529 @default.
- W1998433401 cites W2020659738 @default.
- W1998433401 cites W2021472508 @default.
- W1998433401 cites W2022008771 @default.
- W1998433401 cites W2025122282 @default.
- W1998433401 cites W2031889731 @default.
- W1998433401 cites W2034607173 @default.
- W1998433401 cites W2040956921 @default.
- W1998433401 cites W2041979009 @default.
- W1998433401 cites W2052233064 @default.
- W1998433401 cites W2054162904 @default.
- W1998433401 cites W2065193471 @default.
- W1998433401 cites W2066554862 @default.
- W1998433401 cites W2067666141 @default.
- W1998433401 cites W2081218848 @default.
- W1998433401 cites W2087002320 @default.
- W1998433401 cites W2090926478 @default.
- W1998433401 cites W2092563904 @default.
- W1998433401 cites W2093049209 @default.
- W1998433401 cites W2093136919 @default.
- W1998433401 cites W2096246254 @default.
- W1998433401 cites W2096721022 @default.
- W1998433401 cites W2097854437 @default.
- W1998433401 cites W2100819495 @default.
- W1998433401 cites W2101669068 @default.
- W1998433401 cites W2112378432 @default.
- W1998433401 cites W2115787552 @default.
- W1998433401 cites W2118092611 @default.
- W1998433401 cites W2124569537 @default.
- W1998433401 cites W2128163706 @default.
- W1998433401 cites W2130199362 @default.
- W1998433401 cites W2131917980 @default.
- W1998433401 cites W2134430286 @default.
- W1998433401 cites W2136489990 @default.
- W1998433401 cites W2137747726 @default.
- W1998433401 cites W2139785591 @default.
- W1998433401 cites W2141294691 @default.
- W1998433401 cites W2144471064 @default.
- W1998433401 cites W2146197955 @default.
- W1998433401 cites W2149388786 @default.
- W1998433401 cites W2152623033 @default.
- W1998433401 cites W2158593099 @default.
- W1998433401 cites W2160625453 @default.
- W1998433401 cites W2162508946 @default.
- W1998433401 cites W2166402206 @default.
- W1998433401 cites W2441602433 @default.
- W1998433401 cites W2481569543 @default.
- W1998433401 cites W2567218062 @default.
- W1998433401 cites W2979863292 @default.
- W1998433401 cites W305719300 @default.
- W1998433401 cites W4236484525 @default.
- W1998433401 cites W4241354917 @default.
- W1998433401 cites W4365897483 @default.
- W1998433401 doi "https://doi.org/10.1160/th14-11-0982" @default.
- W1998433401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25832311" @default.
- W1998433401 hasPublicationYear "2015" @default.
- W1998433401 type Work @default.
- W1998433401 sameAs 1998433401 @default.
- W1998433401 citedByCount "135" @default.
- W1998433401 countsByYear W19984334012015 @default.
- W1998433401 countsByYear W19984334012016 @default.
- W1998433401 countsByYear W19984334012017 @default.
- W1998433401 countsByYear W19984334012018 @default.
- W1998433401 countsByYear W19984334012019 @default.
- W1998433401 countsByYear W19984334012020 @default.
- W1998433401 countsByYear W19984334012021 @default.
- W1998433401 countsByYear W19984334012022 @default.
- W1998433401 countsByYear W19984334012023 @default.
- W1998433401 crossrefType "journal-article" @default.
- W1998433401 hasAuthorship W1998433401A5004678737 @default.
- W1998433401 hasAuthorship W1998433401A5059559189 @default.
- W1998433401 hasAuthorship W1998433401A5075868354 @default.
- W1998433401 hasConcept C126322002 @default.
- W1998433401 hasConcept C141071460 @default.
- W1998433401 hasConcept C177713679 @default.
- W1998433401 hasConcept C2776301958 @default.
- W1998433401 hasConcept C2776413415 @default.
- W1998433401 hasConcept C2776710957 @default.